Delves into all aspects of R&D and manufacturing of all oral solid dose (OSD) forms. Tracks industry trends. Relays latest applied research relevant to OSDs. Provides “how to” information for the latest techniques in formulation/excipients, tablet manufacturing, capsule filling and other aspects of the process—including logistics like supply-chain management.
Closing the non-adherence gap will require closer collaboration across the healthcare ecosystem, bringing together formulation scientists, excipient specialists, drug developers, regulators, ...
read more
The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than...
read more
More than six decades after Hovione’s humble basement beginnings, the company is still betting on the value of being global. But today, that means something different. It’s not simply about having ...
read more
The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s.
read more
CDER has approved 33 novel drugs so far, almost half of which are oral solid dose formulations.
read more
Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties.
read more
Spray-dried ASDs are increasingly used to improve bioavailability for complex new molecules, making efficient process development tools and methodologies essential for accelerating commercialization.
read more
While AI offers significant advantages in data processing and analytical capability, its use in regulated industries must be carefully governed. Organizations must balance innovation with compliance ...
read more
Big data and advanced technology have reshaped most industries, and oral solid dose is no exception.
read more
Data-rich, data-led, data-driven — these terms increasingly define modern oral solid dose development. In this roundtable, industry leaders discuss what it will take to navigate this next phase of OSD...
read more
Recent advances are turning what was once a trial-and-error exercise into a disciplined and reproducible design workflow.
read more
As material complexity and regulatory expectations grow, LD-PCRS correlative characterization will support robust formulation design, process control, and risk-based decision-making.
read more
Machinability issues linked to capsule-related factors can disrupt production, increase waste and jeopardize delivery timelines.
read more
As small molecule pipelines continue to shift toward more complex, potent and sensitive APIs and as clinical trials similarly evolve toward greater complexity, the linear model of development is no ...
read more
If history tells us anything, it’s this: in drug delivery, progress doesn’t come in bursts. It flows — steady, adaptable and always moving forward.
read more